Ameriprise
NTRP

Ameriprise’s Neurotrope, Inc. Common NTRP Stock Holding History

Ameriprise’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,000
Closed -$14K – 3794
2019
Q3 		$14K Sell
17,000
-595
-3% -$2.73K ﹤0.01% 3690
2019
Q2 		$141K Sell
17,595
-500
-3% -$3.36K ﹤0.01% 3633
2019
Q1 		$99K Buy
+18,095
New +$77.8K ﹤0.01% 3625

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Ameriprise's NTRP Position: Q4 2019 in Review

Ameriprise sold out of Neurotrope, Inc. Common (NTRP) in Q4 2019, closing a stake of 17,000 shares — an estimated $14K sold.

Ameriprise first reported a position in NTRP in Q1 2019 and held it in 3 quarters. The position peaked at $141K in Q2 2019. 21 funds tracked by Wall St. Rank hold NTRP as of Q4 2019.

  • Ameriprise reported no remaining Neurotrope, Inc. Common position as of Q4 2019 after selling out during the quarter.
  • Ameriprise sold 17,000 Neurotrope, Inc. Common shares in Q4 2019, an estimated $14K.
  • Ameriprise first reported a position in Neurotrope, Inc. Common in Q1 2019 and held it in 3 quarters.
  • Ameriprise's Neurotrope, Inc. Common position peaked at $141K in Q2 2019.
  • 21 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2019.

Based on Ameriprise's 13F filing for Q4 2019, filed 14 Feb 2020.